New blood test uses nanotechnology to predict prostate cancer
A new diagnostic will allow men to bypass painful biopsies to test for aggressive prostate cancer.
List view / Grid view
News
Screening for genetic diseases & chromosomal defects with a single biopsy
Couples who are undergoing pre-implantation genetic diagnosis (PGD) in order to avoid transmission of inherited diseases, such as Duchenne muscular dystrophy or cystic fibrosis, should also have their embryos screened for abnormal numbers of chromosomes at the same time, say Italian researchers.
Major new appetite regulator successfully manipulated in mice
A new study has found a link between certain brain receptors and obesity, giving a possible new drug target for appetite regulation.
Nanoparticle aggregates for destruction of cancer cells
An international team has shown that it is possible to mechanically destroy cancer cells by rotating magnetic nanoparticles attached to them in elongated aggregates.
New WHO Collaborating Centre for Physical Activity and Health
The University of Zurich is launching a new WHO Collaborating Centre for Physical Activity and Health. The Physical Activity and Health Unit and other groups of the Epidemiology, Biostatistics and Prevention Institute will support the Physical Activity Strategy for the World Health Organization (WHO) European Region.
Western diet increases Alzheimer’s pathology in predisposed mice
Obese mice with a particular version of a gene strongly associated with Alzheimer's disease (AD) in humans show increased Alzheimer's pathology, according to new research published in eNeuro.
New cellular imaging paves way for cancer treatment
Researchers have pioneered a technique which uses florescent imaging to track the actions of key enzymes in cancer, genetic disorders and kidney disease.
New cancer drug tested in mice may benefit certain leukaemia patients
Almost 6,000 new cases of acute lymphoblastic leukaemia, or ALL, are expected to be diagnosed this year in the United States. The blood cancer can affect both children and adults.
Balance and movement improved in animal model of Parkinson’s disease
Researchers have developed a molecular compound that improves balance and coordination in mice with early stage Parkinson's disease.
Artificial intelligence to assist in the treatment of heart patients
Artificial intelligence can be used to recognise difficult to predict complications as early as possible within the home care of heart patients.
Arming T-cells to channel aggression against cancer
Scientists have armed immune cells with a new surface molecule that causes them to respond aggressively when they encounter a protein that tumours actually use to camouflage themselves from the immune system. Researchers from the Helmholtz Zentrum München and various partners introduced the method in ‘Cancer Research’.
New leukaemia treatment outperforms standard chemotherapies
Researchers at The Australian National University (ANU) are working on a new treatment for an aggressive type of leukaemia that outperforms standard chemotherapies.
Snake venom might provide a safer antiplatelet drug
In preliminary research, an antiplatelet drug based on a snake venom protein prevented blood clotting without leading to excessive bleeding, a dangerous side effect of currently available antiplatelet drugs. The venom protein may be the template for a new class of antiplatelet drugs that offers fewer bleeding complications.
Newly discovered disease mechanism for type 2 diabetes
A newly discovered mechanism behind reduced insulin production in type 2 diabetes is now being presented.
SOPHiA artificial intelligence empowers liquid biopsies to fight cancer
Sophia Genetics injects artificial intelligence in liquid biopsies to accelerate early detection of cancer and monitor treatments’ effectiveness.
